Supplement-Molecular Sys Biology

Supplement-Molecular Sys Biology

Supplementary Material for: Iwona Stelniec-Klotz, Stefan Legewie, Oleg Tchernitsa, Franziska Witzel, Bertram Klinger, Christine Sers, Hanspeter Herzel, Nils Blüthgen and Reinhold Schäfer: Reverse-engineering a hierarchical regulatory network downstream of oncogenic KRAS Content (9 Figures, 3 Tables, 1 Text, 1 List of References) Supplementary Figures S1: Nuclear protein levels of Fosl1, Hmga2, Klf6, JunB, Otx1, Gfi1, RelA after silencing in KRAS-transformed RAS-ROSE cells. S2: Impact of transcription factor knock-down on the KRAS pathway-mediated mRNA expression profile S3: RNA expression of Fosl1, Hmga2, Klf6, JunB, Otx1, Gfi1, RelA after silencing in KRAS- transformed RAS-ROSE cells S4: Effects of Fosl1, Hmga2, Klf6, JunB, Otx1, Gfi1, RelA knock-down in RAS-ROSE cells on the activity of cytoplasmic signaling downstream of RAS S5: Effect of Fosl1 overepxression and Otx1 knockdown on Fosl1mRNA and phospho-Erk. S6: Effects on growth characteristics of RAS-ROSE cells after silencing Fosl1, Hmga2, Klf6, JunB S7: Effects on growth characteristics of RAS-ROSE cells after silencing Otx1, Gfi1, RelA S8: Effects on distribution of cell cycle phases in KRAS-transformed RAS-ROSE cells after silencing of Fosl1, Hmga2, Klf6, JunB, Otx1, Gfi1, RelA S9: Effect of perturbation strength and noise on algorithm performance. Supplementary Tables S1: Rules for finding transcription factor-related patterns in genome-wide expression data (related to Fig. 3B and C). S2: Known interaction (related to Fig. 4) S3: Quantification of the network. Supplementary Texts Generation of artificial data sets Supplementary References Supplementary Fig. 1 Nuclear protein levels of Fosl1, Hmga2, Klf6, JunB, Otx1, Gfi1, RelA after silencing in KRAS-transformed RAS-ROSE cells. Western Blot analysis of nuclear protein levels of Fosl1, Hmga2, Klf6, JunB, Otx1, Gfi1 and RelA in RAS-ROSE cells 48 h after transfections with scrambled siRNAduplex (Sc), transfection reagents only (Mock) and two independent transcription factor specific siRNAs (1, 2). ß-tubulin control (*). One example of two biological replica is shown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upplementary Fig. 4 Effects of Fosl1, Hmga2, Klf6, JunB, Otx1, Gfi1, RelA knock- down in RAS-ROSE cells on the activity of cytoplasmatic signaling downstream of RAS. Western Blot analysis of phosphorylation of Mek, Erk and Akt 48 h after transfections of Fosl1, Hmga2, Klf6, JunB, Otx1,Gfi1 and RelA in RAS-ROSE cells with two independent transcription factor specific siRNAs (1, 2). Scrambled siRNAduplex (Sc), transfection reagents only (Mock). Loading control for pMek, pErk, pAkt (total Mek, Erk, Akt), control for panRAS (Gapdh). One example of two biological replica is shown. " !"#$="C8D8).DE ! &()%*+ ,---- F9=2; &()=%*+ !"#$%&' - ,,- - !"#$=%>0?@ ./"#./"%,%'0* %$"1%2%3"$4,5/6718 9 = 2 $"1%2%3"$4%A74B5(A"7 9 2 : ; < =9 ! ! Supplementary Fig. 5 Effect of Fosl1 overepxression and Otx1 knockdown on Fosl1 mRNA and phospho-Erk. mRNA levels of ectopically expressed Fosl1 are not influenced by Mek inhibition with U0126, or knockdown of Otx1. Phoshpho-Erk levels tend to rise upon Fosl overexpression and Otx knockdown, ! ! """"""""""""""+5+)+;:58<"""""""""""""""""""""" """""""""""""""""=>>""""""""""""""""""" ,,,,,,,,-"B. ,,,,,,,,,,-CB. ,,,,,,,,-"B. ,,,,,,,,,,-CB. &' &' &' &' ?@A5%,-%. ?@A5%,-%. ?@A5%,-%. ?@A5%,-%. ?@A5%,-". ?@A5%,-". $# ?@A5%,-". $# ?@A5%,-". %"# %"# %!! %!! #! #! $# $# // /// /// /// #&%!'( #! #&%!'( #! "# "# "# "# ! ! ! ! "0 01 $" 23 "0 01 $" 23 01,,,,,,,,,,,,,,$",,,,,,,,,,,,,23 01,,,,,,,,,,,,,,$",,,,,,,,,,,,,23 #&%!)*+!,-,.,+/-0*!1*)023456 #&%!)*+!,-,.,+/-0*!1*)023456 #$% #$% #$% #$% &' &' &' &' ()*+",-%. ()*+",-%. ()*+",-%. ()*+",-%. ()*+",-". ()*+",-". 23456 ()*+",-". $# 23456 $# ()*+",-". %"# %"# )0 )0 %!! %!! #! #! $# $# // / /// // #&%!'( #! #&%!'( #! "# "# "# "# ! ! ! ! "0 01 $" 23 "0 01 $" 23 01,,,,,,,,,,,,,,$",,,,,,,,,,,,,23 01,,,,,,,,,,,,,,$",,,,,,,,,,,,,23 #&%!)*+!,-,.,+/-0*!1* #$% #&%!)*+!,-,.,+/-0*!1* #$% #$% #$% &' &' &' &' 4563,-%. 4563,-%. 4563,-%. 4563,-%. 4563,-". 4563,-". $# 4563,-". $# 4563,-". %"# %"# %!! %!! #! #! $# $# / // // // #&%!'( #&%!'( #! #! "# "# "# "# ! ! ! ! "0 01 $" 23 "0 01 $" 23 01,,,,,,,,,,,,,,$",,,,,,,,,,,,,23 01,,,,,,,,,,,,,,$",,,,,,,,,,,,,23 #&%!)*+!,-,.,+/-0*!1*)023456 #&%!)*+!,-,.,+/-0*!1*)023456 #$% #$% #$% #$% &' &' &' &' 789:,-%. 789:,-%. 789:,-%. 789:,-%. 789:,-". 789:,-". $# 789:,-". $# 789:,-". %"# %"# %!! %!! #! #! // $# $# // #&%!'( #&%!'( #! #! "# "# "# "# ! ! ! ! "0 01 $" 23 "0 01 $" 23 01,,,,,,,,,,,,,,$",,,,,,,,,,,,,23 01,,,,,,,,,,,,,,$",,,,,,,,,,,,,23 #&%!)*+!,-,.,+/-0*!1*)023456 #$% #&%!)*+!,-,.,+/-0*!1*)023456 #$% #$% #$% ! ! '077-*.*63,+8! 94:;! <! !""#$%&' ()'*+(,%-'$-.+.$%#+/&%/$&' ("' 0123042!' $#55&' ."%#+' &/5#)$/)*'("'6(&578'9:*.;8'<5"='.)>'?@)AB!! D<A85EA, 6;@), +9+5FAGA, @6, +9'H@;+*<IJ<K<9J<9E, -"B., +9J, +9'H@;+*<IG9J<K<9J<9E, -CB., *;@LEH, @6, DM&IDN&O, '<55A, 01I23, H, +6E<;, E;<+E)<9E, LGEH, A';+)P5<J, AGDQMI J8K5<R, -&'., +9J, EL@, G9J<K<9J<9E, E;+9A';GKEG@9, 6+'E@;, AK<'G6G', AGDQMA, -%S, "., J<E<;)G9<J, PF, '+5@;G)<E;G', =>>,+9J,+5+)+;:58<, +AA+FAT, >H<, U+58<A,6;@), =>>,E<AE, '@;;<AK@9J,G9,K<;'<9E,E@,&'T,D<A85EA,@6!@9<,;<K;<A<9E+EGU<,+)+5+;:58<,E<AE,+9J,@6,"IC, G9J<K<9J<9E5F, PG@5@*G'+5, =>>, E<AEA, L<;<, G558AE;+E<JT,>H<! '@9EG98@8A5F, )<+A8;<)<9E, @6,+5+)+;:58<,E<AE,GA,G558AE;+E<J,+A,5G9<,*;+KHT,V, ,!S!#=!>>!V, ,!S!%=!>>>!V, ,!S!!%T, !!!!!!!!!!!!!!=8=>=?@8A7!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!BCC!!!!!!!!!!!!!!!!! --------.!D/ ----------.ED/ --------.!D/ ----------.ED/ 01 01 01 01 )*+,-.,/ )*+,-.,/ )*+,-.,/ )*+,-.,/ )*+,-.!/ )*+,-.!/ )*+,-.!/ )*+,-.!/ $( $( ,!( ,!( ,'' ,'' (' (' $( $( -+.(&/('.01234 -+.(&/('.01234 222 222 *) *) 222 222 "%$&56 (' 222 "%$&56 (' 222 !( !( 222 222 !( !( ' ' ' ' !" "# $! %& !" "# $! %& "#--------------$!-------------%& "#--------------$!-------------%& "%$&'()&*+*, "#$ "%$&'()&*+*, "#$ "#$ "#$ 01 01 01 01 345,-.,/ 345,-.,/ 345,-.,/ 345,-.,/ 345,-.!/ 345,-.!/ $( 345,-.!/ $( 345,-.!/ ,!( ,!( ,'' ,'' (' (' $( $( 2 -+.(&/('.01234 -+.(&/('.01234 222 222 222222 222 222 222 *) *) "%$&56 (' "%$&56 (' !( !( 222 222 !( !( &*+*, &*+*, () ' () ' ' ' !" "# $! %& !" "# $! %& "#--------------$!-------------%& "#--------------$!-------------%& "%$&' "#$ "%$&' "#$ "#$ "#$ 01 01 01 01 6789-.,/ 6789-.,/ 6789-.,/ 6789-.,/ 6789-.!/ 6789-.!/ $( 6789-.!/ $( 6789-.!/ ,!( ,!( ,'' ,'' (' (' $( $( 2 222 222 222 222 222 222 222 "%$&56 "%$&56 (' (' !( !( !( !( ' ' ' ' !" "# $! %& !" "# $! %& "#--------------$!-------------%& "#--------------$!-------------%& "%$&'()&*+*,*)-+.(&/('.01234 "#$ "%$&'()&*+*,*)-+.(&/('.01234 "#$ "#$ "#$ 01 01 01 01 :;1< :;1< :;1< :;1< $( $( ,!( ,!( ,'' ,'' (' (' $( $( "%$&56 "%$&56 (' (' !( !( !( !( ' ' ' ' !" "# $! %& !" "# $! %& "#--------------$!-------------%& "#--------------$!-------------%& "%$&'()&*+*,*)-+.(&/('.01234 "#$ "%$&'()&*+*,*)-+.(&/('.01234 "#$ "#$ "#$ & & 5.77+(,(41*)8& 92:;& <& !""#$%&' ()'*+(,%-'$-.+.$%#+/&%/$&' ("' 0123042!' $#55&' ."%#+' &/5#)$/)*'("'4%67'8"/9'.):'0#51;&- 67FA8*F- 4?;>- =G=8HF5F- ;4- =G1I;?=J7KL7M7GL7G*- .!D/- =GL- =G1I;?=J7K5GL7M7GL7G*- .ED/-J?;N*I-;4-690K6)0O-1788F-"#K%&-I-=4*7?-8=F*-*?7=*>7G*-N5*I-F1?=>P87L-F56Q9K LAM87+-.01/R-*?=GF471*5;G-?7=J7G*F-;G8H-.:;1</R-*N;-5GL7M7GL7G*-*?=GF1?5M*5;G-4=1*;?- FM715451- F56Q9F- .,R- !/- L7*7?>5G7L- PH- 1=8;?5>7*?51- BCC- =GL- =8=>=?@8A7- =FF=HFS- 67FA8*F- ;4& ;G7-?7M?7F7G*=*5T7- =>=8=?@8A7- *7F*- =GL- ;4- !KE- 5GL7M7GL7G*8H- P5;8;J51=8- BCC- *7F*F- N7?7- M51*A?7LS- CI7! 1;G*5GA;AF8H- >7=FA?7>7G*- ;4- =8=>=?@8A7- *7F*- 5F- 588AF*?=*7L-=F-85G7-J?=MIS-U- -'R'(=&>>&U- -'R',=&>>>&U- -'R'',S- ! ! ! !"##$%&%'()*+, -./0, 1, !""#$%&' ()' *+&%,+-.%+()' ("' $#//' $0$/#' 123&#&' +)' 45678 %,3)&"(,9#*'56785:7!'$#//&'3"%#,'&+/#)$+);'("'<(&/=>'?9;3@>'4/"A>'B.)C>':%D=>'E"+=>' 5#/6F'' !"#$%&#' ()*+' ,"%%' ,-,%"' ./.%-#0#' *(' !123!425' ,"%%#' 67'8'.(&")' &)".&+"/&' 90&8'

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    16 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us